Steven A. Shallcross, CEO of Theriva Biologics TOVX, has filed 7 purchases and 0 sales on the open market. The latest trade was on 01/05.

SS

SS

Steven A. Shallcross

CEO and CFO

Company

Theriva Biologics TOVX

First filing

23/01/03

Trades

13 trades

Buys / sales

7 / 0

12-month net buying

No record

Last trade

01/05

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Theriva BiologicsTOVX	Open-market buy	23/06/07	23/06/08	14,000 sh	$0.69	$9,660	+5.9%
Theriva BiologicsTOVX	Open-market buy	23/06/06	23/06/07	26,000 sh	$0.63	$16,380	+12.4%
Theriva BiologicsTOVX	Open-market buy	23/02/10	23/02/13	25,000 sh	$1.04	$26,000	+13.5%
Theriva BiologicsTOVX	Open-market buy	23/02/02	23/02/03	25,000 sh	$0.94	$23,500	+15.6%
Theriva BiologicsTOVX	Open-market buy	23/01/25	23/01/26	25,000 sh	$0.87	$21,750	+18.5%
Theriva BiologicsTOVX	Open-market buy	23/01/20	23/01/23	25,000 sh	$0.75	$18,750	+22.7%
Theriva BiologicsTOVX	Open-market buy	22/12/29	23/01/03	100,000 sh	$0.44	$44,000	+1000.0%